Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (NASDAQ:MATN)

0.6023
Delayed Data
As of 3:07pm ET
 +0.0023 / +0.38%
Today’s Change
0.49
Today|||52-Week Range
1.23
-20.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues156.0K95.0K0.000.00
 
 
 
Depreciation And Amortization127.0K110.0K109.0K20.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----109.0K-20.0K
 
 
 
General Expenses8.1M8.3M12.5M13.7M
 
 
 
 
 
Research And Development3.5M3.6M7.4M9.1M
 
 
 
 
 
Total Operating Expenses8.2M8.4M12.7M13.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.1M-8.3M-12.7M-13.7M
 
 
 
 
 
Extraordinary Credit6.0K0.00--0.00
 
 
Extraordinary Charge-15.0K0.00--0.00
 
 
Other Expenses-25.0K-1.0K-3.0K1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-8.3M-12.6M-13.7M
 
 
 
 
 
Preferred Dividend0.00-4.8M0.000.00
 
 
Net Income-8.1M-8.3M-12.6M-13.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.8M17.0M25.2M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.8M17.0M25.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.48-$4.67-$0.75-$0.54
 
 
 
 
 
EPS Diluted-$5.48-$4.67-$0.75-$0.54